Acta Biomaterialia,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Dec. 1, 2024
Acute
neuroinflammation,
which
is
notably
characterized
by
a
significant
elevation
in
pro-inflammatory
cytokines
and
chemokines,
often
rapidly
develops
following
traumatic
spinal
cord
injury
exacerbates
damage
the
lesion
area.
This
study
addresses
limitations
inherent
strategies
that
regulate
only
single
or
few
cytokines,
are
insufficient
to
counteract
progression
of
secondary
injuries.
We
explore
use
polydopamine
nanoparticles
as
broad-spectrum
immunomodulator,
capable
capturing
adsorption
wide
range
thereby
effectively
suppressing
neuroinflammation.
Leveraging
their
adhesive
properties,
these
promptly
reduce
levels
various
excessive
including
IL-1α,
IL-1β,
IL-6,
IL-10,
IL-17A,
IL-18,
TNF-α,
MCP-1,
GRO/KC,
M-CSF,
MIP-3α,
IFN-γ,
primarily
through
physical
adsorption.
reduction
cytokine
contributes
subsequent
inhibition
M1
microglia
A1
astrocyte
activation,
aiding
recovery
motor
functions
vivo.
In
summary,
represent
versatile
effective
approach
for
modulating
acute
neuroinflammation
By
broadly
down-regulating
propose
an
innovative
treating
STATEMENT
OF
SIGNIFICANCE:
The
current
demonstrated
immunomodulatory
potential
mitigating
injury.
Both
vitro
vivo
analyses
revealed
downregulation
several
key
among
panel
23
chemokines.
underlying
mechanisms
governing
interactions
were
elucidated
comprehensive
molecular
dynamics
simulations
first
time.
Consequently,
chemokines
led
activation
both
models.
protected
neurons
within
microenvironment,
resulting
improved
locomotor
functions.
Overall,
this
underscores
prominent
therapeutic
efficacy
alleviating
highlighting
regulators
intricate
microenvironments.
Journal of Neuroinflammation,
Journal Year:
2025,
Volume and Issue:
22(1)
Published: Jan. 31, 2025
CAAT/Enhancer
Binding
Protein
β
(C/EBPβ)
is
associated
with
inflammatory
responses
in
neurodegenerative
pathologies,
particularly
the
brain.
However,
regulatory
role
of
C/EBPβ
spinal
cord
injury
and
its
impact
on
neurological
recovery
remain
unknown.
In
this
study,
we
observed
significant
upregulation
microglia
after
mice
was
neuroinflammation.
Knocking
down
attenuated
pyroptosis,
reduced
production
proinflammatory
cytokines,
inhibited
neuronal
apoptosis.
Mechanistically,
promoted
transcription
Fcgr1,
which
involved
activating
pyroptosis.
both
in-vivo
in-vitro
experiments,
knocking
Cebpb
or
pyroptosis
inhibitor
VX765
apoptosis
improved
mice.
These
findings
indicate
that
functions
as
a
key
regulator
participates
pyroptosis-mediated
neuroinflammation
by
Fcgr1
transcription.
Macromolecular Bioscience,
Journal Year:
2024,
Volume and Issue:
unknown
Published: May 11, 2024
Abstract
The
targeted
delivery
of
drugs
using
wireless
navigable
magnetic
robots
allows
the
drug
molecules
to
be
controlled
non
only
in
time
but
also
space,
improving
medical
outcomes.
main
disadvantages
behind
their
use
lies
low
amount
that
can
transported
and
single
nature
loaded
(hydrophilic
or
hydrophobic).
These
considerations
limit
co‐delivery
systems,
now
recognized
very
promising
for
many
different
pathologies.
A
bijel‐like
structure
is
developed
load
release
types
In
this
work,
ε‐caprolactone
explored,
which
polymerize,
forming
hydrophobic
domains
(oil
phase).
After
mixing
with
iron
oxide
nanoparticles
(NPs),
water
dispersion
creates
a
biphasic
porous
without
phase
separation.
resulting
device
shows
good
performance
both
actuation
as
system.
Journal of Translational Medicine,
Journal Year:
2025,
Volume and Issue:
23(1)
Published: Jan. 13, 2025
Spinal
cord
injury
(SCI)
triggers
a
complex
inflammatory
response
that
impedes
neural
repair
and
functional
recovery.
The
modulation
of
macrophage
phenotypes
is
thus
considered
promising
therapeutic
strategy
to
mitigate
inflammation
promote
regeneration.
We
employed
microarray
single-cell
RNA
sequencing
(scRNA-seq)
investigate
gene
expression
changes
immune
cell
dynamics
in
mice
following
crush
at
3
7
days
post-injury
(dpi).
High-dimensional
co-expression
network
analysis
(hdWGCNA)
slingshot
trajectory
were
identify
key
modules
differentiation
pathways.
Subsequently,
immunofluorescence
staining,
flow
cytometry,
western
blotting
performed
validate
the
identified
effects
amantadine
on
inflammation.
To
elucidate
molecular
mechanisms
underlying
transcriptional
level,
we
followed
by
set
enrichment
(GSEA).
results
revealed
pathways
related
phagocytosis
activation
are
significantly
involved
post-injury,
shedding
light
regulatory
role
macrophages
SCI
repair.
further
within
injured
spinal
cord,
conducted
scRNA-Seq,
identifying
three
distinct
subtypes:
border-associated
(BAMs),
(IMs),
chemotaxis-inducing
(CIMs).
Trajectory
suggested
pathway
from
Il-1b+
IMs
Mrc1+
BAMs,
subsequently
Arg1+
CIMs,
indicating
potential
maturation
process.
Given
importance
these
response,
utilized
docking
hypothesize
might
modulate
this
Subsequent
vitro
vivo
experiments
demonstrated
reduces
facilitates
transition
BAMs
likely
through
HIF-1α
NF-κB
This
promotes
regeneration
enhances
recovery
SCI.
Amantadine
modulates
SCI,
early
responses,
function
These
findings
highlight
as
treatment
for
provide
foundation
future
translational
research
into
its
clinical
applications.
Materials Today Bio,
Journal Year:
2024,
Volume and Issue:
27, P. 101117 - 101117
Published: June 13, 2024
Spinal
cord
injury
(SCI)
is
a
devastating
condition
that
can
cause
significant
motor
and
sensory
impairment.
Microglia,
the
central
nervous
system's
immune
sentinels,
are
known
to
be
promising
therapeutic
targets
in
both
SCI
neurodegenerative
diseases.
The
most
effective
way
deliver
medications
control
microglial
inflammation
through
nanovectors;
however,
because
of
variability
morphology
lack
standardized
techniques,
it
still
difficult
precisely
measure
their
activation
preclinical
models.
This
problem
especially
important
SCI,
where
intricacy
glia
response
following
traumatic
events
necessitates
use
sophisticated
method
automatically
discern
between
various
cell
states
vary
over
time
space
as
secondary
progresses.
We
address
this
issue
by
proposing
deep
learning-based
technique
for
quantifying
drug-loaded
nanovector
treatment
model.
Our
uses
convolutional
neural
network
segment
classify
microglia
based
on
morphological
characteristics.
approach's
accuracy
efficiency
demonstrated
evaluation
collection
histology
pictures
from
injured
intact
spinal
cords.
robust
computational
has
potential
analyzing
across
neuropathologies
demonstrating
usefulness
nanovectors
modifying
other
neurological
disorders.
It
ability
speed
development
crucial
sector
providing
objective
compare
options.
Biomedicine & Pharmacotherapy,
Journal Year:
2024,
Volume and Issue:
177, P. 117011 - 117011
Published: June 24, 2024
Microglia
are
essential
for
maintaining
homeostasis
and
responding
to
pathological
events
in
the
central
nervous
system
(CNS).
Their
dynamic
multidimensional
states
different
environments
pivotal
factors
various
CNS
disorders.
However,
therapeutic
modulation
of
microglial
is
challenging
due
intricate
balance
these
cells
maintain
environment
blood-brain
barrier's
restriction
drug
delivery.
Nanomedicine
presents
a
promising
avenue
addressing
challenges,
offering
method
targeted
efficient
states.
This
review
covers
challenges
faced
potential
use
nanoparticle-based
delivery
systems.
We
provide
an
in-depth
examination
nanoparticle
applications
modulating
range
disorders,
encompassing
neurodegenerative
autoimmune
diseases,
infections,
traumatic
injuries,
stroke,
tumors,
chronic
pain,
psychiatric
conditions.
highlights
recent
advancements
future
prospects
nanomedicine
modulation,
paving
way
research
clinical
interventions
Gels,
Journal Year:
2024,
Volume and Issue:
10(3), P. 162 - 162
Published: Feb. 21, 2024
Extracellular
vesicles
(EVs),
especially
exosomes,
have
shown
great
therapeutic
potential
in
the
treatment
of
diseases,
as
they
can
target
cells
or
tissues.
However,
effect
EVs
is
limited
due
to
susceptibility
immune
system
clearance
during
transport
vivo.
Hydrogels
become
an
ideal
delivery
platform
for
their
good
biocompatibility
and
porous
structure.
This
article
reviews
preparation
application
EVs-loaded
hydrogels
a
cell-free
therapy
strategy
diseases.
The
also
discusses
challenges
future
outlook
hydrogels.